Clean Science Management Guidance Tracker

6 forward-looking guidance items tracked across 2 quarters.

Expansion

Q3 FY26Performance Chemical 2 to commercialize in Q1 FY27Tracked

The PC2 plant is expected to start production by May-June 2026, with revenues beginning in Q4 FY27 after teething issues and customer approvals.

Q4 FY26Performance Chemical 2 commercialization by September 2026Tracked

The new plant for water treatment chemicals is expected to be commercialized by September 2026, with validation in Q3 and revenue contribution from Q4 FY27.

Growth

Q3 FY26HALS 50% utilization target over 2 yearsTracked

Management reiterated its guidance of achieving 50% utilization for the HALS plant over a 2-year period from commercialization.

Other

Q3 FY26No further promoter dilution in next couple of yearsTracked

Management stated that the Bhoop family is unlikely to sell any further shares in the next couple of years, even after the lock-in period.

Capex

Q4 FY26Capex budget of ₹80-100 crore for FY27Tracked

Management guided a capex range of ₹80-100 crore for the upcoming fiscal year, primarily for debottlenecking and backward integration.

Margins

Q4 FY26Health subsidiary margin improvement through backward integrationTracked

Backward integration into key intermediates for health products is expected to improve margins and reduce import dependence, though no specific target was given.